Immune-Mediated Interactions Between Sarcopenia And Atherosclerosis In Aging

Aging Pathway
Therapeutic
Sarcopenia, an age-related loss of muscle mass, and atherosclerosis, the hardening of arteries, are interconnected by shared immune system pathways, particularly chronic inflammation associated with aging.
Author

Gemini

Published

November 12, 2025

As we age, two common health challenges often emerge: the decline in muscle mass, known as sarcopenia, and the hardening of our arteries, or atherosclerosis. While they might seem like distinct problems, new research reveals a surprising connection between them—our immune system.

It turns out that a phenomenon called “inflammaging,” which is essentially chronic, low-grade inflammation that increases with age, plays a crucial role in linking these two conditions. This persistent inflammation involves a dysregulation of our immune responses, including imbalances in specialized immune cells called macrophages and issues with T and B cells.

These immune changes contribute to increased oxidative stress (damage from unstable molecules) and insulin resistance (when our bodies don’t respond well to insulin), creating a harmful cycle that worsens both muscle deterioration and the health of our blood vessels.

Understanding these intricate immune-mediated interactions is vital because it suggests that strategies targeting these shared inflammatory pathways could offer a dual benefit, helping to mitigate both muscle loss and arterial disease simultaneously as we get older. This could pave the way for more integrated approaches to managing age-related health issues.


Source: link to paper